Evidence-Based Managementof Osteoporosis：骨质疏松症的证据为基础的管理.pptVIP

Evidence-Based Managementof Osteoporosis A Systematic Review of Agents Currently Available for Osteoporosis and their Use in Clinical Practice Benefits of Therapy: Summary Contemporary pharmacologic treatments significantly decrease fracture risk: “Antiresorptive” therapy produces a modest increase in bone mineral density (BMD) However, decreases in fracture risk—especially in the spine—occur much faster and to a larger extent than predicted by the relatively small change in BMD. This implies an important improvement in bone “quality” Anabolic therapy with teriparatide increases BMD mor